Samuel D. Waksal
(1947-)
American businessman
About
Jump to
Samuel D. "Sam" Waksal (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.
Key details
edit section
| Born |
8 September 1947 (age 77) Paris, France_|_Paris, France
|
| Zodiac | Virgo |
| Tags | Add tag |
Partner
Family members
Romantic interests
Friends & associates
Scholars
Please be the first to contribute to this page!
Missing information for Samuel D. Waksal
- missing gender
- missing height
- missing hair color
- missing eye color
- missing ethnicity
- add profile photo
- add banner photo
- add photos to gallery
- missing current partner
Similar profiles
10
Activity
Top contributors today
Be the first to contribute today
Tags
Featured contributors
Couples by country
USA · UK · Canada · Australia · France · Germany · India · China · South Korea · Japan · Spain · MexicoCouples by decade
1900s · 1910s · 1920s · 1930s · 1940s · 1950s · 1960s · 1970s · 1980s · 1990s · 2000s · 2010s · 2020sADVERTISEMENT
ADVERTISEMENT
